VLCC to open 50 institutes in India; plans to go international

New Delhi: Beauty and wellness firm VLCC is on the expansion spree with a target to add 50 new training institutes in India over the next five years.

The company, which has about 70 institutes in India, has also chalked out plans to foray into international markets such as Canada, Malaysia, Srilanka, Kenya, Oman and Bangladesh.

With the opening of more institutes, VLCC is eyeing a 35 per cent year on year revenue growth. In FY 2018, it had a turnover of Rs 55 crore for the skilled business.

“We will add 50 new institutes in India and also in countries such as Canada, Malaysia, Oman and Srilanka with a target to train approximately 15,000 students,” VLCC Group Director Sandeep Ahuja told .

The company offers about 100 courses and workshops in the beauty and wellness space and has trained over 1 lakh students so far.

The institutes have crossed Rs 50 crore target and is set to go over Rs 100 crore with international expansion by this fiscal end, as per the company.

With regard to retail expansion in the personal care category, Ahuja said VLCC has recently added close to 100 new distributors and is betting on the modern trade across national and regional customers besides giving leverage to the e-commerce.

The contribution from e-commerce was close to 15 per cent in FY 2018. Total turnover from personal care category stood at Rs 400 crore in the last financial year. The company has 197 wellness centres in India and markets over 169 skincare, haircare, bodycare, functional foods and fortified food products.

  • Related Posts

    Lilly launches Mounjaro KwikPen in India

    Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India